![]() |
|||
|
Research | Core Facilities | Patient Studies | Tech Transfer | Seminars | Intranet | Careers | Search | Contact Us | Ways To Give HOME |
|||
|
Core Facilities Clinical Immunology Signal Transduction Shared Facilities Laboratory Animal Institutional Animal
|
Another type of autoimmune disease attacks the muscles of the body. The "myositis-specific antibodies" (MSA) can assist in the diagnosis of polymyositis and dermatomyositis in those patients who have the diseases. About 50% of patients with polymyositis or dermatomyositis have specific MSA or myositis associated antibodies (MAA). MSA are almost never found in patients without myositis, even if they have other muscle diseases of autoimmune diseases. This means that when the physician's examination and initial testing suggests the possibility of polymyositis or dermatomyositis, a positive test for an MSA can be strong supporting evidence for the diagnosis. For a long time the testing for these antibodies was only available in research studies,
but it is now possible to obtain this testing clinically. The Myositis Profile, performed at the OMRF
Clinical Immunology Laboratory, includes tests for 12 of the MSAs and MAAs. Additional antibodies may be
detectable using this profile. Dr. Ira Targoff is the consultant to the Clinical Immunology
Laboratory regarding this testing. As with the Reichlin Profile for lupus, patients with a particular
antibody may have distinctive clinical pictures with certain associated problems. Identifying certain
antibodies can help characterize the condition more fully. Research continues in our lab, and others
around the world, to determine the nature of the relationship between the various MSAs and polymyositis
and dermatomyositis.
Requisition Form - Word format Specimen Handling - Word format Price List - Word format
For more information regarding the OMRF Clinical Laboratory please call Mary Jones at (405) 271-7395, or the laboratory staff at (405) 271-7771.
|
||